Advertisement

Perianal Hidradenitis Suppurativa

  • Emily Steinhagen
  • Michael F. McGeeEmail author
Chapter

Abstract

Hidradenitis suppurativa is a rare, debilitating, chronic inflammatory disease that manifests with painful lesions, sinuses, and fistulae. The axilla, groin, and perineal regions are most frequently affected. There may be overlap and/or diagnostic confusion with Crohn’s disease in the perianal region. A variety of strategies for medical management, including anti-TNF-α agents, may ameliorate the disease course. Surgery is considered the most definitive and effective treatment and may require reconstruction in areas of difficult anatomy such as the perineal region.

Keywords

Hidradenitis suppurativa Perianal Fistula Crohn’s disease 

Abbreviations

CD

Crohn’s disease

HS

Hidradenitis suppurativa

SCC

Squamous cell carcinoma

VAC

Vacuum assisted closure

References

  1. 1.
    van Rappard DC, Mekkes JR, Tzellos T. Randomized controlled trials for the treatment of hidradenitis suppurativa. Dermatol Clin. 2016;34(1):69–80.PubMedGoogle Scholar
  2. 2.
    Zouboulis CC, Desai N, Emtestam L, Hunger RE, Ioannides D, Juhasz I, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015;29(4):619–44.PubMedGoogle Scholar
  3. 3.
    Shlyankevich J, Chen AJ, Kim GE, Kimball AB. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis. J Am Acad Dermatol. 2014;71(6):1144–50.PubMedGoogle Scholar
  4. 4.
    Jemec GB. Clinical practice. Hidradenitis suppurativa. N Engl J Med. 2012;366(2):158–64.PubMedGoogle Scholar
  5. 5.
    Vlassova N, Kuhn D, Okoye GA. Hidradenitis suppurativa disproportionately affects African Americans: a single-center retrospective analysis. Acta Derm Venereol. 2015;95(8):990–1.PubMedGoogle Scholar
  6. 6.
    Miller IM, Ellervik C, Vinding GR, Zarchi K, Ibler KS, Knudsen KM, et al. Association of metabolic syndrome and hidradenitis suppurativa. JAMA Dermatol. 2014;150(12):1273–80.PubMedGoogle Scholar
  7. 7.
    van der Zee HH, van der Woude CJ, Florencia EF, Prens EP. Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot study. Br J Dermatol. 2010;162(1):195–7.PubMedGoogle Scholar
  8. 8.
    Attanoos RL, Appleton MA, Douglas-Jones AG. The pathogenesis of hidradenitis suppurativa: a closer look at apocrine and apoeccrine glands. Br J Dermatol. 1995;133(2):254–8.PubMedGoogle Scholar
  9. 9.
    Kelly G, Hughes R, McGarry T, van den Born M, Adamzik K, Fitzgerald R, et al. Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa. Br J Dermatol. 2015;173(6):1431–9.PubMedGoogle Scholar
  10. 10.
    van der Zee HH, Prens EP. The anti-inflammatory drug colchicine lacks efficacy in hidradenitis suppurativa. Dermatology. 2011;223(2):169–73.PubMedGoogle Scholar
  11. 11.
    Emelianov VU, Bechara FG, Glaser R, Langan EA, Taungjaruwinai WM, Schroder JM, et al. Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversa. Br J Dermatol. 2012;166(5):1023–34.PubMedGoogle Scholar
  12. 12.
    van der Zee HH, Laman JD, de Ruiter L, Dik WA, Prens EP. Adalimumab (antitumour necrosis factor-alpha) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study. Br J Dermatol. 2012;166(2):298–305.PubMedGoogle Scholar
  13. 13.
    Schroder K, Tschopp J. The inflammasomes. Cell. 2010;140(6):821–32.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Canoui-Poitrine F, Le Thuaut A, Revuz JE, Viallette C, Gabison G, Poli F, et al. Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a cross-sectional study. J Invest Dermatol. 2013;133(6):1506–11.PubMedGoogle Scholar
  15. 15.
    Pink AE, Simpson MA, Desai N, Dafou D, Hills A, Mortimer P, et al. Mutations in the gamma-secretase genes NCSTN, PSENEN, and PSEN1 underlie rare forms of hidradenitis suppurativa (acne inversa). J Invest Dermatol. 2012;132(10):2459–61.PubMedGoogle Scholar
  16. 16.
    Gao M, Wang PG, Cui Y, Yang S, Zhang YH, Lin D, et al. Inversa acne (hidradenitis suppurativa): a case report and identification of the locus at chromosome 1p21.1-1q25.3. J Invest Dermatol. 2006;126(6):1302–6.PubMedGoogle Scholar
  17. 17.
    Wang B, Yang W, Wen W, Sun J, Su B, Liu B, et al. Gamma-secretase gene mutations in familial acne inversa. Science. 2010;330(6007):1065.PubMedGoogle Scholar
  18. 18.
    Yadav S, Singh S, Edakkanambeth Varayil J, Harmsen WS, Zinsmeister AR, Tremaine WJ, et al. Hidradenitis suppurativa in patients with inflammatory bowel disease: a population-based cohort study in Olmsted County, Minnesota. Clin Gastroenterol Hepatol. 2016;14(1):65–70.PubMedGoogle Scholar
  19. 19.
    Wortsman X. Imaging of hidradenitis suppurativa. Dermatol Clin. 2016;34(1):59–68.PubMedGoogle Scholar
  20. 20.
    Wortsman X, Moreno C, Soto R, Arellano J, Pezo C, Wortsman J. Ultrasound in-depth characterization and staging of hidradenitis suppurativa. Dermatol Surg. 2013;39(12):1835–42.PubMedGoogle Scholar
  21. 21.
    Clemmensen OJ. Topical treatment of hidradenitis suppurativa with clindamycin. Int J Dermatol. 1983;22(5):325–8.PubMedGoogle Scholar
  22. 22.
    Join-Lambert O, Coignard-Biehler H, Jais JP, Delage M, Guet-Revillet H, Poiree S, et al. Efficacy of ertapenem in severe hidradenitis suppurativa: a pilot study in a cohort of 30 consecutive patients. J Antimicrob Chemother. 2016;71(2):513–20.PubMedGoogle Scholar
  23. 23.
    Jemec GBE, Revuz J, Leyden J, editors. Hidradenitis suppurativa. Berlin: Springer; 2006. p. 138–40.Google Scholar
  24. 24.
    Grant A, Gonzalez T, Montgomery MO, Cardenas V, Kerdel FA. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial. J Am Acad Dermatol. 2010;62(2):205–17.PubMedGoogle Scholar
  25. 25.
    Kimball AB, Kerdel F, Adams D, Mrowietz U, Gelfand JM, Gniadecki R, et al. Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial. Ann Intern Med. 2012;157(12):846–55.PubMedGoogle Scholar
  26. 26.
    Cusack C, Buckley C. Etanercept: effective in the management of hidradenitis suppurativa. Br J Dermatol. 2006;154(4):726–9.PubMedGoogle Scholar
  27. 27.
    Giamarellos-Bourboulis EJ, Pelekanou E, Antonopoulou A, Petropoulou H, Baziaka F, Karagianni V, et al. An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa. Br J Dermatol. 2008;158(3):567–72.PubMedGoogle Scholar
  28. 28.
    Adams DR, Yankura JA, Fogelberg AC, Anderson BE. Treatment of hidradenitis suppurativa with etanercept injection. Arch Dermatol. 2010;146(5):501–4.PubMedGoogle Scholar
  29. 29.
    Machet L, Samimi M, Delage M, Paintaud G, Maruani A. Systematic review of the efficacy and adverse events associated with infliximab treatment of hidradenitis suppurativa in patients with coexistent inflammatory diseases. J Am Acad Dermatol. 2013;69(4):649–50.PubMedGoogle Scholar
  30. 30.
    Kamal N, Cohen BL, Buche S, Delaporte E, Colombel JF. Features of patients with Crohn’s disease and hidradenitis suppurativa. Clin Gastroenterol Hepatol. 2016;14(1):71–9.PubMedGoogle Scholar
  31. 31.
    Cosmatos I, Matcho A, Weinstein R, Montgomery MO, Stang P. Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States. J Am Acad Dermatol. 2013;68(3):412–9.PubMedGoogle Scholar
  32. 32.
    Janse I, Bieniek A, Horvath B, Matusiak L. Surgical procedures in hidradenitis suppurativa. Dermatol Clin. 2016;34(1):97–109.PubMedGoogle Scholar
  33. 33.
    Mullins JF, McCash WB, Boudreau RF. Treatment of chronic hidradenitis suppurativa: surgical modification. Postgrad Med. 1959;26:805–8.PubMedGoogle Scholar
  34. 34.
    Culp CE. Chronic hidradenitis suppurativa of the anal canal. A surgical skin disease. Dis Colon Rectum. 1983;26(10):669–76.PubMedGoogle Scholar
  35. 35.
    van der Zee HH, Prens EP, Boer J. Deroofing: a tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions. J Am Acad Dermatol. 2010;63(3):475–80.PubMedGoogle Scholar
  36. 36.
    Ritz JP, Runkel N, Haier J, Buhr HJ. Extent of surgery and recurrence rate of hidradenitis suppurativa. Int J Color Dis. 1998;13(4):164–8.Google Scholar
  37. 37.
    Bieniek A, Matusiak L, Okulewicz-Gojlik D, Szepietowski JC. Surgical treatment of hidradenitis suppurativa: experiences and recommendations. Dermatol Surg. 2010;36(12):1998–2004.PubMedGoogle Scholar
  38. 38.
    Mehdizadeh A, Hazen PG, Bechara FG, Zwingerman N, Moazenzadeh M, Bashash M, et al. Recurrence of hidradenitis suppurativa after surgical management: a systematic review and meta-analysis. J Am Acad Dermatol. 2015;73(5 Suppl 1):S70–7.PubMedGoogle Scholar
  39. 39.
    Morgan WP, Harding KG, Hughes LE. A comparison of skin grafting and healing by granulation, following axillary excision for hidradenitis suppurativa. Ann R Coll Surg Engl. 1983;65(4):235–6.PubMedPubMedCentralGoogle Scholar
  40. 40.
    Eray IC, Alabaz O, Akcam AT, Ulku A, Parsak CK, Sakman G, et al. Comparison of diverting colostomy and bowel management catheter applications in Fournier gangrene cases requiring fecal diversion. Indian J Surg. 2015;77(Suppl 2):438–41.PubMedGoogle Scholar
  41. 41.
    Losanoff JE, Sochaki P, Khoury N, Levi E, Salwen WA, Basson MD. Squamous cell carcinoma complicating chronic suppurative hydradenitis. Am Surg. 2011;77(11):1449–53.PubMedGoogle Scholar
  42. 42.
    Pena ZG, Sivamani RK, Konia TH, Eisen DB. Squamous cell carcinoma in the setting of chronic hidradenitis suppurativa; report of a patient and update of the literature. Dermatol Online J. 2015;21(4)Google Scholar
  43. 43.
    Lavogiez C, Delaporte E, Darras-Vercambre S, Martin De Lassalle E, Castillo C, Mirabel X, et al. Clinicopathological study of 13 cases of squamous cell carcinoma complicating hidradenitis suppurativa. Dermatology. 2010;220(2):147–53.PubMedGoogle Scholar
  44. 44.
    Herschel S, Laske J, Stein A. Squamous cell carcinoma arising in hidradenitis suppurativa. J Dtsch Dermatol Ges. 2014;12(5):417–9.PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  1. 1.University HospitalsClevelandUSA
  2. 2.Department of Surgery, Division of Gastrointestinal and Oncologic Surgery, Section of Colon and Rectal SurgeryFeinberg School of Medicine, Northwestern UniversityChicagoUSA

Personalised recommendations